English version

  • Sauta E et al. CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer. Cancers (Basel). 2021 Jul 12;13(14):3477.
  • Schiroli D, et al. Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer. Diagnostics (Basel). 2021.

  • Reggiani F et al. An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma. Mol Cancer. 2021 Apr 6;20(1):63.

  • Gugnoni M et al. Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6. Thyroid. 2021 Feb;31(2):247-263.

  • Rossi T et al. RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer. Mol Cancer Res. 2020 Jan;18(1):140-152.

  • Merolle, L et al. Mapping fundamental life elements in papillary thyroid carcinoma tissue. J Instrumentation. 2018.

  • Sancisi V et al. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN. Nucleic Acids Res. 2017.

  • Gugnoni M et al. Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy. Oncogene. 2017.

Ultimo aggiornamento: 20/12/21